Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study) ; volume:22 ; number:1 ; day:14 ; month:7 ; year:2022 ; pages:1-8 ; date:12.2022
BMC gastroenterology ; 22, Heft 1 (14.7.2022), 1-8, 12.2022
- Urheber
-
Iimura, Yohei
Furukawa, Naoki
Ishibashi, Masaaki
Ahiko, Yuka
Tanabe, Taro
Aikou, Susumu
Shida, Dai
Nojima, Masanori
Kuroda, Seiichiro
Boku, Narikazu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-022-02411-w
- URN
-
urn:nbn:de:101:1-2022091622215609009181
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Iimura, Yohei
- Furukawa, Naoki
- Ishibashi, Masaaki
- Ahiko, Yuka
- Tanabe, Taro
- Aikou, Susumu
- Shida, Dai
- Nojima, Masanori
- Kuroda, Seiichiro
- Boku, Narikazu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Phase I pharmacological study of continuous chronomodulated capecitabine treatment
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
Docetaxel, Oxaliplatin with Capecitabine (TEX Regimen) in Metastatic Gastric and Gastroesophageal Adenocarcinoma: A Prospective Single-Arm Observational Study from a Tertiary Cancer Center in Kashmir
Capecitabine-Associated Terminal Ileitis
Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study
Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study
Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Phase I pharmacological study of continuous chronomodulated capecitabine treatment
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
Docetaxel, Oxaliplatin with Capecitabine (TEX Regimen) in Metastatic Gastric and Gastroesophageal Adenocarcinoma: A Prospective Single-Arm Observational Study from a Tertiary Cancer Center in Kashmir
Capecitabine-Associated Terminal Ileitis
Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study
Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study
Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Phase I pharmacological study of continuous chronomodulated capecitabine treatment
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
Docetaxel, Oxaliplatin with Capecitabine (TEX Regimen) in Metastatic Gastric and Gastroesophageal Adenocarcinoma: A Prospective Single-Arm Observational Study from a Tertiary Cancer Center in Kashmir
Capecitabine-Associated Terminal Ileitis
Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study
Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study
Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study